Artificial intelligence (AI) is transforming the field of oligonucleotide therapy by revolutionizing drug discovery, target identification and manufacturing procedures. AI tools analyze large datasets, identify potential genetic targets and predict the outcomes of oligonucleotide therapeutics. AI plays a significant role in identifying patient-specific genetic variations that may influence treatment outcomes. AI models can also be used to gather real-world evidence and monitor the long-term effects of oligonucleotide therapy.
Many companies in the U.S., such as Amgen Inc., Alnylam Pharmaceuticals Inc. and Eli Lilly, are utilizing AI-based technologies for drug discovery, manufacturing operations and the optimization of clinical trials.
The report includes:
- Impact analysis of artificial intelligence (AI) on the global oligonucleotides market landscape
- Case studies for successful integration of AI and machine learning (ML)-based algorithms in for enzymatic oligonucleotide synthesis, patient care and accelerated oligonucleotide drug development
- Highlights of AI adoption trends across the major geographical regions as well as disruptions caused by AI across key industry verticals
- Review of AI impact on the various stages of the global supply chain analysis
- Competitive landscape featuring strategic initiatives, market spendings and venture funding outlook
Many companies in the U.S., such as Amgen Inc., Alnylam Pharmaceuticals Inc. and Eli Lilly, are utilizing AI-based technologies for drug discovery, manufacturing operations and the optimization of clinical trials.
The report includes:
- Impact analysis of artificial intelligence (AI) on the global oligonucleotides market landscape
- Case studies for successful integration of AI and machine learning (ML)-based algorithms in for enzymatic oligonucleotide synthesis, patient care and accelerated oligonucleotide drug development
- Highlights of AI adoption trends across the major geographical regions as well as disruptions caused by AI across key industry verticals
- Review of AI impact on the various stages of the global supply chain analysis
- Competitive landscape featuring strategic initiatives, market spendings and venture funding outlook
Table of Contents
Chapter 1 Key Use Cases for AI Adoption in the Oligonucleotides Market- Overview
- Key Use Cases
- Use Case 1: Machine Learning Integration for Enzymatic Oligonucleotide Synthesis
- Use Case 2: AI-Driven RNA-Based Drug Discovery
- Use Case 3: Patient Care
- Use Case 4: Machine Learning (ML) to Expedite Oligonucleotide Drug Development
- AI Adoption Trends at the Regional Level
- Adoption Trends in North America
- Adoption Trends in Europe
- Adoption Trends in Asia-Pacific
- Adoption Trends in the Rest of the World
- Impact of AI on Key Industry Verticals in the Oligonucleotides Market
- Drug Discovery
- Clinical Trials and Optimization
- Optimizing Delivery Systems
- Impact of AI on Various Stages of the Value Chain
- Overview
- Market Spending and Forecasting Analysis
- Abbreviations
Table 1: Examples of Investments in AI in the Oligonucleotides Market, 2023-2025
Table 2: Abbreviations Used in the Oligonucleotides Market Report
List of Figures
Figure 1: Impact of AI on the Oligonucleotides Value Chain
